Posts Tagged ‘drug pricing’
No DIR Reform in CMS’ 2020 Final Drug Pricing Rule
Despite over 4,000 comments from pharmacists and organizations like Currus, NCPA, the National Association of Chain Drug Stores (NACDS), and others across the country encouraging change, CMS elected not to address DIR reform in their final 2020 drug pricing rule released on Thursday. CMS said in a statement that they “will continue to carefully review…
Read MorePresident Signs ‘Gag Clause’ Bills into Law
Today, President Trump signed two bills into law that will allow pharmacists to disclose the lowest cost of prescriptions to their patients. Previously, pharmacy benefit managers (PBMs) have enforced so-called “gag clauses” that prohibited pharmacists from informing their patients if they could purchase their prescriptions for a lower cost out-of-pocket vs. through insurance. The Patient…
Read More